Exenatide: a guide to its use as an adjunct to metformin and/or a sulfonylurea in patients with type 2 diabetes mellitus

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 23, Iss. 10, 2007-10 ,pp. : 5-8

Adis International

Access to resources Recommend Favorite

Exenatide Extended-Release: A Review of Its Use in Type 2 Diabetes Mellitus

By Scott Lesley J.  

Drugs, Vol. 72, Iss. 12, 2012-08 ,pp. : 1679-1707

Adis International

Access to resources Recommend Favorite

An Economic Evaluation of Colesevelam when Added to Metformin-, Insulin- or Sulfonylurea-Based Therapies in Patients with Uncontrolled Type 2 Diabetes Mellitus

By Simons W. Robert   Hagan Michael A.  

PharmacoEconomics, Vol. 28, Iss. 9, 2010-09 ,pp. : 765-780

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Saxagliptin and Metformin versus Sulfonylurea and Metformin in the Treatment of Type 2 Diabetes Mellitus in Germany: A Cardiff Diabetes Model Analysis

By Erhardt Wilma  

Clinical Drug Investigation, Vol. 32, Iss. 3, 2012-03 ,pp. : 189-202

Adis International

Access to resources Recommend Favorite

Combination therapy in type 2 diabetes mellitus: adding linagliptin to a stable regimen of metformin and a sulfonylurea

By Aronson Ronnie  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 10, 2012-07 ,pp. : 1535-1539

Informa Healthcare

Access to resources Recommend Favorite